Ron Bentsur

2022 - Nuvectis Pharma

In 2022, Ron Bentsur earned a total compensation of $1.7M as President & Chief Executive Officer at Nuvectis Pharma.

Compensation breakdown

Bonus$431,250
Salary$420,360
Stock Awards$842,400
Total$1,694,010

Bentsur received $842.4K in stock awards, accounting for 50% of the total pay in 2022.

Bentsur also received $431.3K in bonus and $420.4K in salary.

Rankings

In 2022, Ron Bentsur's compensation ranked 2,009th out of 5,676 executives tracked by ExecPay. In other words, Bentsur earned more than 64.6% of executives.

ClassificationRankingPercentile
All
2,009
out of 5,676
65th
Division
Manufacturing
1,072
out of 3,084
65th
Major group
Chemicals And Allied Products
458
out of 1,399
67th
Industry group
Drugs
420
out of 1,300
68th
Industry
Pharmaceutical Preparations
303
out of 942
68th
Source: SEC filing on April 29, 2024.

Bentsur's colleagues

We found two more compensation records of executives who worked with Ron Bentsur at Nuvectis Pharma in 2022.

2022

Enrique Poradosu

Nuvectis Pharma

Chief Scientific & Business Officer

2022

Shay Shemesh

Nuvectis Pharma

Chief Development & Operations Officer

News

You may also like